ArticleInfection & chemotherapy2026

Long-term Immunogenicity and Safety Profile of the Adjuvanted RSVPreF3 Vaccine in Korean Older Adults: A Sub-analysis of a Phase 3 Trial.

Seong-Beom Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.